Research article
375 views
Understanding real-world adherence in the directly acting antiviral era: A prospective evaluation of adherence among people with a history of drug use at a community-based program in Toronto, Canada
The International journal on drug policy, vol. 47, pp. –, 2017
Abstract
This study demonstrates that strong adherence and SVR with DAAs is achievable, with appropriate supports, even in the context of substance use, and complex health/social issues.
Keywords
- hepatitis c
- canada
- National Center for Biotechnology Information
- NCBI
- NLM
- MEDLINE
- humans
- pubmed abstract
- nih
- national institutes of health
- national library of medicine
- research support
- non-u.s. gov't
- female
- male
- middle aged
- Prospective Studies
- drug therapy
- combination
- antiviral agents / therapeutic use*
- primary health care
- chronic / drug therapy*
- sustained virologic response
- Opiate Substitution Treatment
- pmid:28619394
- doi:10.1016/j.drugpo.2017.05.025
- kate mason
- zoë dodd
- jeff powis
- community health services*
- drug users / psychology*
- chronic / psychology*
- medication adherence*
- vulnerable populations / psychology*
How to cite
Mason K; Dodd Z; Guyton M; Tookey P; Lettner B; Matelski J; Sockalingam S; Altenberg J; Powis J. (2017). Understanding real-world adherence in the directly acting antiviral era: A prospective evaluation of adherence among people with a history of drug use at a community-based program in Toronto, Canada. The International journal on drug policy, 47, –. http://www.ncbi.nlm.nih.gov/pubmed/28619394
Ref key
k2017theunderstanding
Type this key in a SciMatic manuscript or in Thesis Manager to cite this paper automatically.
References
No references are recorded for this paper yet.
